Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Publication Timetable

This timetable will be updated when publication dates are finalised.

Dental Q3 2025/26

29th January 2026

Ophthalmic Q3 2025/26

5th February 2026

General Medical Q3 2025/26 12th February 2026
Sodium Valproate Monitoring Report – Q3 2025/26

19th February 2026

Topiramate Monitoring Report – Q3 2025/26 19th February 2026
Pharmaceutical Services Q3 2025/26

26th February 2026

Prescription Cost Analysis 2025

26th February 2026

Sodium Valproate Monitoring Report – Q4 2025/26

May 2026

Topiramate Monitoring Report – Q4 2025/26 May 2026
General Medical Q4 2025/26

June 2026

General Medical Annual 2025/26

June 2026

Ophthalmic Q4 2025/26

June 2026

Ophthalmic Annual 2025/26 June 2026
Dental Q4 2025/26

June 2026

Dental Annual 2025/26

June 2026

Pharmaceutical Services Q4 2025/26

June 2026

Pharmaceutical Annual 2025/26

June 2026

FPS Key Facts Annual 2025/26

July 2026

Dental Q1 2026/27

July 2026

Ophthalmic Q1 2026/27

August 2026

General Medical Q1 2026/27

August 2026

Sodium Valproate Monitoring Report – Q1 2026/27

August 2026

Topiramate Monitoring Report – Q1 2026/27 August 2026
Pharmaceutical Services Q1 2026/27

August 2026

Dental Q2 2026/27

October 2026

Ophthalmic Q2 2026/27

November 2026

General Medical Q2 2026/27 November 2026
Sodium Valproate Monitoring Report – Q2 2026/27

November 2026

Topiramate Monitoring Report – Q2 2026/27

November 2026

Pharmaceutical Services Q2 2026/27

November 2026

 

The Prescription Cost Analysis is normally published annually in February, with annual General Medical, Ophthalmic, Dental and Pharmaceutical publications in June and the Annual Key Facts publication in July.

Monthly datasets, such as GP Prescribing and Dispensing by Contractor, are dependent on the completion of pharmacy payment processes but will be published on or before the 10th of each month.